Report: Clovis looks to cash in on the bull market for biotechs

John Carroll Bloomberg reports that Clovis is ready to pack it in and see if it can find a buyer at a blockbuster price. The business news service's sources say that Clovis has ...

Anti-obesity Drug Market to Increase by 2019, But Stigma Remains

mia.burns Anti-obesity drug market to reach $ 2.6 billion in 2019 Although obesity cases are high, only small percentage of ‘patients are treated with pharmacotherapy,’ says ...

Stigma and other factors limit anti-obesity market growth

mia.burns By Mia Burns (mia.burns@ubm.com) The off-patent orlistat, also known as Roche’s Xenical, dominates the anti-obesity drug market, and the market is expected to grow from ...

GlobalData report explores antibiotics market opportunity

mia.burns By Mia Burns (mia.burns@ubm.com)  The rising demand for antibiotics to counter increasing cases of drug-resistant infections, combined with decreasing R&D costs, is ...

Analyst briefing details growth strategies within Russian healthcare market

mia.burns By Mia Burns Several fundamentals of the Russian healthcare industry continue to be strong, according to Frost & Sullivan. Large population base, growing middle class ...

Waksal brushes off jail time, plots biotech IPOs in a red-hot market

John Carroll A bullish Sam Waksal hopes to banish the ethical cloud that has hung over his head since doing jail time for the Imclone insider trading scandal with plans to spin some ...

Study: Biogen hemophilia drugs will allow market to thrive

mia.burns By Mia Burns (mia.burns@ubm.com) Eloctate and Alprolix, Biogen Idec’s hemophilia drug candidates, are positioned to capture a significant share of the hemophilia market ...

Bayer’s Eylea challenges Novartis eye drug for share of new market

Tracy Staton Bayer's Eylea has a new field for fighting Lucentis. The eye drug won a new approval in Europe, in patients with macular degeneration due to central retinal vein occlusion, ...

China probes of Glaxo, Sanofi, others put big chill on key growth market

Eric Palmer The recent, and very public, Chinese investigation into bribery allegations against GlaxoSmithKline and others has doctors running scared, making it tough for everyone to ...

Report projects global orphan drug market to tap $112 billion in 2017

mia.burns By Mia Burns The total market value for orphan drugs is expected to hit $ 112 billion in 2017 after increasing at a five-year compound annual growth rate of 5.4 percent, ...

Global Ubiquitin Proteasome Research and Development Market to Surpass $5.5 Billion by 2018: BCC Research

mia.burns Wellesley, Mass. – According to a new technical market research report, UBIQUITIN PROTEASOME: GLOBAL MARKETS FOR RESEARCH TOOLS, DIAGNOSTICS AND DRUG DISCOVERY (Report ...

Global Market for Orphan Drugs is Expected to Reach $112 Billion in 2017

mia.burns Wellesley, Mass. – In the new report, GLOBAL MARKETS FOR ORPHAN DRUGS (PHM038D), from BCC Research (www.bccresearch.com), the global market for orphan drugs was valued ...
Page 4 of 8« First...23456...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS